ALK and neoplasm: After data normalization and quality control steps, we identified 42,752 and 12,354 significant methylation variable positions (MVPs) between tumor (ALK+ or ALK−) and normal control (CD3+ T cells) (based on M value calculation and adjusted p < 0.01) (Figure 1A).